scispace - formally typeset
A

Andrew Bosworth

Researcher at University Hospitals Birmingham NHS Foundation Trust

Publications -  45
Citations -  2358

Andrew Bosworth is an academic researcher from University Hospitals Birmingham NHS Foundation Trust. The author has contributed to research in topics: Medicine & Ebola virus. The author has an hindex of 16, co-authored 35 publications receiving 1277 citations. Previous affiliations of Andrew Bosworth include National Institute for Health Research & Bernhard Nocht Institute for Tropical Medicine.

Papers
More filters
Journal ArticleDOI

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.

Katherine A Twohig, +607 more
TL;DR: In this paper, the authors compared the severity of the delta variant compared with the alpha variant by determining the relative risk of hospital attendance outcomes and found that outbreaks of the Delta variant in unvaccinated populations might lead to a greater burden on health-care services than the alpha variants.
Journal ArticleDOI

Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa

Miles W. Carroll, +131 more
- 06 Aug 2015 - 
TL;DR: Deep sequencing of 179 patient samples processed by the European Mobile Laboratory, the first diagnostics unit to be deployed to the epicentre of the outbreak in Guinea, reveals an epidemiological and evolutionary history of the epidemic from March 2014 to January 2015, providing an unprecedented window into the evolution of an ongoing viral haemorrhagic fever outbreak.
Journal ArticleDOI

A Susceptible Mouse Model for Zika Virus Infection.

TL;DR: A129 mice are identified as being highly susceptible to ZIKV and thus A129 mice represent a suitable, and urgently required, small animal model for the testing of vaccines and antivirals.
Journal ArticleDOI

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

Brian J. Willett, +672 more
- 07 Jul 2022 - 
TL;DR: In this article , the authors demonstrate substantial evasion of neutralization by Omicron BA.1 and BA.2 variants in vitro using sera from individuals vaccinated with ChAdOx1, BNT162b2 and mRNA-1273.529.